Sponsor pipeline

Omar Nadeem, MD clinical trial pipeline

Get alerts when Omar Nadeem, MD's trials change

3 active trials 1 recruiting 1 disease areas 1 changes in 30 days

Data updated daily from ClinicalTrials.gov, last refresh 2026-10-11

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Phase 1/2
2
Phase 2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 2
NCT04775550 DARA RVD For High Risk SMM High-risk Smoldering Multiple Myeloma Active, Not Recruiting 2026-07-02
Phase 1/2
NCT06518551 Elotuzumab + Iberdomide + Dexamethasone Post Ide-Cel in RRMM Myeloma Recruiting 2026-10-07
NCT04094961 Ixazomib + Pomalidomide + Dexamethasone In MM Multiple Myeloma Active, Not Recruiting 2026-03-05

Disease areas by active trials

Multiple Myeloma (3)

Get alerts when Omar Nadeem, MD's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free